Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05150093 · ClinicalTrials.gov registry record · NA
Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor
A NA study of Dystonia and Tremor, sponsored by Massachusetts Eye and Ear Infirmary.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05150093: Recruiting NA study of Dystonia and Tremor, sponsored by Massachusetts Eye and Ear Infirmary.
NCT05150093 is a NA study of Dystonia and Tremor that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 120 participants, below the 536-participant average among 28 other Dystonia trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05150093, a NA study of Dystonia and Tremor, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this project are 1) to determine the incidence of neurological voice disorders in patients with dystonia and essential tremor undergoing deep brain stimulation (DBS), 2) investigate the neuroimaging and intracranial neurophysiology correlates of voice dysfunction in these subjects, and subsequently 3) determine the effects of DBS on voice function.
Primary Outcome
Analysis of intraoperative recordings from deep basal ganglia structures and cortical regions relevant to voice and speech control.
Conditions Studied
Interventions
- PROCEDURE Deep Brain Stimulation
Study Locations (1)
Massachusetts
- Massachusetts General Hospital, University of California San Francisco, University of Utah - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-06-21 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT05150093 shows while recruiting
NCT05150093 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 536-participant average among 28 other Dystonia trials with a reported enrollment target (78% lower).
The record links to 4 conditions, with Dystonia appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation is the first listed.
NCT05150093 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05150093 about?
NCT05150093 is a clinical study titled "Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor". The goals of this project are 1) to determine the incidence of neurological voice disorders in patients with dystonia and essential tremor undergoing deep brain stimulation (DBS), 2) investigate the neuroimaging and intracranial neurophysiology correlates of voice dysfunction in these subjects, and ...
What is the current status of trial NCT05150093?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-06-21. Estimated completion is 2027-08-31.
What conditions does trial NCT05150093 study?
This clinical trial studies the following conditions: Dystonia, Tremor, Laryngeal Dystonia, Spasmodic Dysphonia.
What interventions are being tested in trial NCT05150093?
The interventions under investigation include: Deep Brain Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT05150093?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05150093 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dystonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05150093's enrollment target sits among peer trials
120 11th of 28 higher than 18 of 28 other Dystonia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dystonia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Exercise on Dystonia Pathophysiology
RECRUITING · NA
-
Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia
RECRUITING · NA
-
Sleep-specific DBS Therapy in Parkinson's Disease
RECRUITING · NA
-
Deep Brain Stimulation Surgery for Movement Disorders
RECRUITING · NA
-
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
RECRUITING · NA
-
Cortical-Basal Ganglia Speech Networks
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI